AEGR
Aegerion Pharmaceuticals
AEGR
AEGR
Delisted
AEGR was delisted on the 29th of November, 2016.
150 hedge funds and large institutions have $2.22B invested in Aegerion Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 56 increasing their positions, 55 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
11% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 36
14% less capital invested
Capital invested by funds: $2.59B → $2.22B (-$373M)
Holders
150
Holding in Top 10
7
Calls
$124M
Puts
$113M
Top Buyers
| 1 | +$108M | |
| 2 | +$38.1M | |
| 3 | +$34.9M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$33.4M |
| 5 |
HM
HealthCor Management
New York
|
+$30.2M |
Top Sellers
| 1 | -$133M | |
| 2 | -$37.7M | |
| 3 | -$22.8M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$22.7M |
| 5 |
CCI
Columbus Circle Investors
|
-$20.1M |